XORTX Therapeutics Inc (TSE:XRTX) has released an update.
XORTX Therapeutics Inc. has announced its intention to lower the exercise price of over 1.1 million outstanding warrants to USD $5.00 per share. This significant pricing adjustment affects warrants issued from three separate private placements in 2021 and 2022, originally priced much higher in CAD. The amendment of the warrant terms is contingent on both warrant holder acceptance and TSX Venture Exchange approval.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.
